It was disheartening to have a "pristine" CDMO that has won awards etc. on being top flight in processes and manufacturing excellence and watching Lilly stop their covid work because their QC was bad. If we were doing some of it the price here would be $30 and get done right. I'm seriously thinking we are just too far off anyone's radar. The big boys anyway.
Expansion funding. IMO, PPHM/CDMO has a history of diluting current shares to obtain funding. I think we stay in $7-8 range until that issue is settled.